Ann K. Cunningham is listed as a director on 2 SEC Form D filings by 1 issuer between Dec 2019 and Jan 2020: VistaGen Therapeutics, Inc. (South San Francisco, CA — pharmaceuticals — 2019–2020; $4.78M reported sold to 129 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Ann K. Cunningham and found 2 differences: Form D filed 43 days after the first sale; Industry group changed between filings.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.